Impact of Comorbid Hypertension and Diabetes on Anti-VEGF Treatment Outcomes in Macular Edema. [PDF]
Lu W, Yang S, Zheng C, Wu Z.
europepmc +1 more source
Efficacy and Safety of an Indian Bevacizumab BIOSimilar (BEVATAS) for Treatment-Naïve Diabetic Macular Edema (BIOS-DME Study). [PDF]
Chakraborty S +3 more
europepmc +1 more source
Effects of anti-VEGF therapy on choroidal thickness in eyes with diabetic macular edema. [PDF]
Shi XN +4 more
europepmc +1 more source
Interferon as a novel agent for management of macular edema: Where do we stand? [PDF]
Kawali A +4 more
europepmc +1 more source
Pathogenetic Mechanism of Macular Edema During Treatment with Ibrutinib. [PDF]
Mauro C +9 more
europepmc +1 more source
Optical Coherence Tomography Biomarkers in Diabetic Macular Edema and Their Role in Predicting Visual Outcome After Ranibizumab or Triamcinolone Injection. [PDF]
Palanisamy S +6 more
europepmc +1 more source
The Comparison of Intracystic Hyperreflectivity in Different Macular Edema Etiologies. Is It a New Optical Coherence Tomography Biomarker? [PDF]
Uzundede T +3 more
europepmc +1 more source
Early Prediction of Diabetic Macular Edema via Machine Learning Survival Analysis on Checkup Data. [PDF]
Kashiwagi Y +15 more
europepmc +1 more source
Comparison of topical nepafenac 0.1% and 0.3% for the treatment of pseudophakic cystoid macular edema following cataract surgery. [PDF]
Çakmak S +5 more
europepmc +1 more source
Suprachoroidal injection in the treatment of diabetic macular edema: mechanisms, clinical advances, and future perspectives. [PDF]
Chen M, Jiao W, Liu T, Zhao B.
europepmc +1 more source

